Smoking Intervention Among Patients With Diabetes
The Effectiveness of a Tobacco Cessation Intervention Program Among Patients With Diabetes at Penang Hospital: a Randomised Controlled Trial
The Effectiveness of a Tobacco Cessation Intervention Program Among Patients With Diabetes at Penang Hospital: a Randomised Controlled Trial
Sponsor study identifier
Secondary identifiers
OTHER · Clinical Research Centre (CRC)
interventional
126
1 country
1
Study Start
May 5, 2011
Actual (reported)Primary Completion
September 1, 2012
Actual (reported)Study Completion
December 1, 2012
Actual (reported)This study determined the prevalence of tobacco smoking among patients with diabetes and evaluated the impact of a diabetes-specific tobacco cessation intervention on tobacco cessation outcomes and on the glycaemic control, blood pressure, lipid profile, complications, comorbidities and number of cigarettes consumed per day among the patients.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 1, 2012
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 5, 2011
Actual (reported)September 1, 2012
Actual (reported)December 1, 2012
Actual (reported)April 24, 2021
Actual (reported)April 28, 2021
Actual (reported)quitting rate
stop smoking
12 months
HbA1c
glucose level
12 months
TriGlycerides, Low Density Lipoprotien, High Density Lipoprotien
12 MONTHS
BP(systolic and diastolic blood pressure)
12 MONTHS
Usual care
5 minutes brief smoking cessation advise
The tobacco cessation protocol consisted of performing a routine assessment (asking) of cigarette use; providing advice on the importance of quitting; performing an assessment of the tobacco user's readiness to quit; assisting in setting a quit date; and making arrangements for follow-up visits. This protocol is popularly known as the 5A's strategy (The first 3A's should be delivered to all smokers regardless of their willingness to quit). Tobacco users were identified by staff nurses. Clinicians provided brief advice on quitting, and the researcher assessed the patient's dependence and readiness to quit. Patients who were not ready to quit were motivated to consider quitting, whereas those who were ready to quit were referred to practitioners who could assist them and follow them in the tobacco cessation clinic
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Khansaa Albaroodi
Karbala, Others, 56001, Iraq
Ibrahim AKA, Syed Sulaiman SA, Awaisu A, Shafie AA. Impact of brief smoking cessation intervention on quitting rate and glycemic control in patients with diabetes: a randomized controlled trial. J Int Med Res. 2023 Oct;51(10):3000605231208598. doi: 10.1177/03000605231208598.
Khansaa Albaroodi
PhD clinical pharmacy
126 participants (actual enrollment reported by the registry).
First Submitted
April 24, 2021
First Posted
April 28, 2021
Study Start
May 5, 2011
Actual (reported)Integrating the "Ottawa Model" for Smoking Cessation Into Primary Care Practice
Contact the study team to confirm eligibility.
Primary Completion
September 1, 2012
Actual (reported)Study Completion
December 1, 2012
Actual (reported)Last Updated
May 6, 2021
Record last verified: 2021-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: